We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App





Excitement and Anticipation Surround the 2023 AACC Annual Scientific Meeting

By Jen A. Miller (AACC)
Posted on 07 Jul 2023
What’s it like to spend more than a year planning a scientific meeting for 20,000 people, and then be on the precipice of all that work being realized? More...
“Exciting,” said Amy Saenger, PhD, DABCC, FAACC, chair of AACC’s 12-member volunteer Annual Meeting Organizing Committee (AMOC). She expressed her anticipation as the meeting is set to return to pre-COVID-19 attendance numbers for the first time in years.

CLN spoke to her about the process of planning this year’s meeting and what attendees should expect.

WHAT ARE YOU LOOKING FORWARD TO THE MOST ABOUT THIS YEAR’S MEETING?
I’m mostly looking forward to having it be more like a normal meeting again, with almost everything in person. We expect attendance numbers to be back to or exceeding where they were prepandemic. I think we’re all looking forward to just getting back to ‘normal.’”

At the same time, we’re also offering virtual options for some of our sessions. We’ve improved the delivery of virtual content to ensure attendees can access the information they need. While our aim is to have people attend in person, we acknowledge that it may not work for everyone, so we want to ensure they have the opportunity to participate.

HOW HAVE CHANGES IN LAB MEDICINE AFFECTED THE CONTENT OF THE MEETING?
We've taken a targeted approach and conducted extensive outreach for our sessions, which has been incredibly successful. The content now showcases more innovative approaches to lab medicine, expanding beyond the traditional laboratory setting. For example, during the pandemic, clinical laboratories adapted their testing methods to serve homeless shelters, correctional facilities, and long-term care facilities. We’ll have sessions exploring these novel approaches and a broader focus on population health.

Clinical laboratorians have a lot of exciting things to share. We’re going to see a lot of cutting-edge science that’s coming out of lab medicine and clinical chemistry.

WHAT ELSE CAN ATTENDEES EXPECT THIS YEAR?
For this meeting, we’ve made a lot of changes to the format of the program that the AMOC is enthusiastic about. For example, we opened the poster sessions to all attendees, whether they’re expo only attendees or full conference attendees. We did that because we’re trying to increase the visibility of the posters and abstract presentations for everybody. It’s a good and significant change.

We also changed the topics of the posters and the abstracts to better align with our AACC divisions, and we are hoping to increase attendance there. If divisions decide to do poster walks again, they can more easily do so. This is a return to how we did things a few years ago, and we realized this worked well, so we made the change.

We also were able to work with the AACC’s journal Clinical Chemistry so that all our abstracts are indexed in the journal. I believe this also will boost visibility for all our authors, who put a lot of time and effort into doing these studies and presenting them.

Overall, attendees can expect to see a lot of excellent cutting-edge science and research in the field of laboratory medicine, and they should expect to have a lot of fruitful discussions and collaborations with their colleagues and other professionals in the field.


Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Turbidimetric Control
D-Dimer Turbidimetric Control
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.